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Summary
Objective: To identify human papillomavirus type 16 (HPV16) E6 and L1 molecular variants
infecting Guarani Indian women settled in Misiones, Argentina, a region with a high prevalence of
cervical cancer. Some intratypic molecular variants of HPV16 have been associated with greater
oncogenic risk, but their implication in the etiology of cervical cancer is still uncertain.
Methods: Seventy HPV16 positive cervical samples from Guarani Indian women settled in two
different areas of Misiones, Argentina, (34 from the northern area and 36 from the central area),
were analyzed. Thirty-seven had normal cytology, 18 had a low-grade squamous intraepithelial
lesion (LGSIL), and 15 a high-grade squamous intraepithelial lesion (HGSIL). HPV16 E6 and L1
molecular variants were identified by PCR, followed by dot blot hybridization with 23 and 12
biotinylated oligonucleotide probes, respectively.
Results: The frequency of HPV16 variants over the Guarani population was 51% EP (European
prototype), 32% E-350G, 9% Af1-a (African 1), 4% E-6862C, 3% Af2-a, and 1% AA-a (Asian-
American). The distribution of variants was not homogeneous in the two areas under analysis,
with the northern area being more diverse showing 74% of European variants, while the central
area presented exclusively E variants. No statistically significant association was found between
any particular variant and grade of cervical lesion.
Conclusion: This study reports for the first time HPV16 E6 and L1 molecular variants infecting
women from an aboriginal community inhabiting a rainforest region of South America. The
presence of E class variants could be attributed primarily to contacts with the Spanish* Corresponding author. Tel.: +54 3752 435118; fax: +54 3752 435118.
E-mail address: labimap@mbf.unam.edu.ar (S.A. Tonon).
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conquerors, and Af variants from African slaves introduced later in the South American
continent.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.Introduction
More than 490 000 new cases of cervical cancer occur among
women worldwide each year. Incidence rates of this disease
vary from about 5 cases per 100 000 women per year in many
industrialized countries to more than 50 per 100 000 in some
developing nations.1 Approximately 80% of all cases occur in
less-developed countries, because prevention programs are
either non-existent or poorly conducted.
High-risk types of mucosotropic human papillomaviruses
(HPVs) are associated with more than 96% of cervical cancers
worldwide, with HPV16 detected in about 50% of them.2
However, HPV16 is also themost common typeofHPV infecting
the normal population, and only a minority of women with
HPV16 infection develop invasive cervical cancer.3 It has now
been well established that high-risk HPV cervical infection
plays a significant role in the initiation andprogression through
various stages of cervical intraepithelial neoplasias (CINs) to
invasive cancer.4,5 Nevertheless, the evolution of primary viral
infection to CINs and cancer is dependent on several factors,
many of which are still unknown.6,7
HPV genotypes have been commonly used as the exposure
measure for HPV-associated risk for invasive cervical carci-
noma, considering that different types of HPVs vary in tissue
affinity and pathogenicity.2 It becomes important then to
consider biological modifiers of HPV-associated disease risk,
such as the presence and role of sequence variation within
HPVs as it may relate to risk for invasive cancer.8
For all HPV types studied to date, intratypic variants have
been identified.9—12 These variants differ from the reference
viral type sequence in the L1 coding region by up to 2.0% and
show different geographic distribution.13 In particular, HPV16
variants are distributed differently among the five continents:
Asian (A) variants are mainly in Southeast Asia, African (Af)
variants are mainly in Africa, European (E) variants are in all
regions other than Africa, and Asian-American (AA) variants
are located mainly in Central, South America and Spain.11,14
The possibility that differences in biologic characteristics
might also be present among intratypic HPV16 variants
deserves consideration. Some of them have already
been associated with CINs or more aggressive cervical can-
cers.15—20 Therefore determining the natural HPV16 variants
present in populations showing high incidence of cervical
lesions and cancer is of particular interest in view of their
potential association, and for the design of HPV16 vaccine
strategies.
The province of Misiones is located at the northeastern tip
of Argentina sharing international borders with Paraguay and
Brazil, and retains the last remnant of rainforest of the area.
Misiones is considered a region with both a high incidence of
cervical carcinoma (33/100 000) and HPV genital infection in
the urban population.21
The Guarani Indians inhabit the rainforest of Misiones,
being around 1700 in total, concentrated in more than 20
small communities. Until the last decade, the Indian socialunits had been self-sustaining, avoiding direct exchanges
with the white population of urban areas. However, recent
economic and ecological factors have generated an impor-
tant change in the Indian—white relationship, compelling
male Indians to integrate with the rural work-force in
white-run agricultural establishments.
Guarani women begin sexual activity early, after
menarche; they have multiple sexual partners and are multi-
parous. Some of their partners have already had intercourse
with white women of neighboring towns. This abrupt social
change has had a direct impact on the Indian community
health status, bringing a significant increase in sexually
transmitted and respiratory diseases.
This situation led us to conduct the first reported cervical
HPV infection screening study among sexually active Guarani
women resident in the region, representative of a particular
community beginning to interact with the urban popula-
tion.22 In this research, a cross-sectional cytological and
HPV screening study of the nine main Indian settlements
was conducted. Demographic data, information about sexual
behavior, and gynecological history were recorded. Nearly all
Guarani women screened had some grade of cervical disease,
including in situ carcinomas. Generic HPV infection preva-
lence was elevated (64%), with predominance of high-risk
types 16/18 (26%). A large variety of other viral types were
also detected, including high- to intermediate-risk types not
found previously in the urban population of the region. These
epidemiological results led us to propose the existence of an
HPV high-risk type viral reservoir in the Indian community.
The purpose of the present study was to characterize class
and subclass variants of HPV16 from this group of Guarani
Indian women based on the analysis of the E6 and L1 viral
genes, and to analyze putative associations with observed
cervical lesions.
Materials and methods
Study population
Seventy cervical samples from Guarani Indian women
infected with HPV16 were obtained from a community-based
cervical HPV infection screening conducted by the authors
during the years 2002—2003.22 Informed consent was
obtained from their guardians.
The general population characteristics are presented in
Table 1. The median age was 20 years, 60% being younger than
30. This particular age distribution is common among Guarani
Indians, mainly due to high mortality rates of those above 40
years of age caused by different infectious diseases. Themean
age of first intercoursewas 13 years and first pregnancy was 15
years. Polygamy reached 80% and the illiteracy rate 87%, as
expected in this particular semi-closed society. Ninety-four
percent had had no previous gynecological examination.
The 70 HPV16 infected women were distributed over two
different geographical regions; 34 in the northern area of the
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Table 1 General characteristics of the group of Guarani
women under study
Characteristic
Age range (years) 15—45
Median (years) 20
Educational level
No instruction 87%
Elementary instruction 13%
Complete general instruction 0%
Previous gynecological examination
Yes 6%
No 94%
Age of first intercourse
>19 years old 1.6%
17—19 years old 7.8%
14—16 years old 44.3%
<14 years old 46.3%
Partners
1 20.8%
2—5 65.7%
>5 13.5%
Pregnancies
1 13.9%
2—5 44.4%
>5 41.7%Misiones province, at the borders with Brazil and Paraguay,
and 36 in the central area, deep into the rainforest, far away
from the borders (Figure 1).
Samples
HPV16 positive samples selected for variant analysis were
previously identified and typified by PCR and PCR—RFLP
(restriction fragment length polymorphism).22,23 Histopatho-Figure 1 Geographical locations of Guarlogic diagnoses for these samples included 37 within normal
limits, 18 low-grade squamous intraepithelial lesions (LGSIL),
and 15 high-grade squamous intraepithelial lesions (HGSIL).
Identification of HPV16 E6 and L1 variants
The identification of HPV16 E6 and L1 variants was done by
the method proposed by Wheeler et al.24 In brief, a one-tube
nested PCR was performed to amplify a 585 bp region of the
E6 gene and a two-tube nested PCR for a 423 bp region of the
L1 gene from HPV16. The amplification products were iden-
tified by dot blot hybridization. Twenty-three and 12 bioti-
nylated oligonucleotide probes were used for E6 and L1
fragment hybridization, respectively. The nucleotide varia-
tions targeted by these probes included HPV16 E6 nucleotide
positions 109, 131, 132, 143, 145, 178, 183, 286, 289, 335,
350, 403, and 532 and L1 nucleotide positions 6695, 6721,
6803, 6854, 6862, and 6694.
Immediately prior to hybridization with HPV16 lineage-
specific oligonucleotide probes, membranes were pretreated
at 65 8C in 0.1X SSPE containing 0.5% sodium dodecyl sulfate
(SDS) under vigorous shaking conditions. Hybridizations with
biotinylated probes (1.0 pmol of probe per 50 mL of hybridiza-
tion solution) were conducted overnight in 5 SSPE containing
0.1% SDS at 42.5 8C. Membranes were then subjected to two
consecutive 10-min washes with 2 liters of 2 SSPE that had
been prewarmed at a previously standardized temperature,
and further incubated with 2 SSPE—0.1% SDS containing
30 ng/mL of streptavidin peroxidase for 20 min at room tem-
perature and constant shaking. Later, the membranes were
washed twice with 2 SSPE—0.1% SDS with constant shaking
for 10 min each and incubated for 1 min in 10 mL of a mixture
for enhanced chemiluminescent substrate reagents (ECL;
Amersham, Arlington Heights, IL, USA) following the manu-
facturer’s instructions. Exposure to Kodak X-OMAT AR-5 film
was for 2 and 10 min or for 2 h. Positive controls used included
HPV16 clones of each variant under study.
E6 and L1 hybridization assay results were interpreted
from the chemiluminescent signals recorded on X-ray film.
Linked results were used to establish an overall hybridizationani settlements included in this study.
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Table 4 Distribution of HPV16 variants among samples
regarding histopathological status
HPV16
variant
Normal Total in
lesions
LGSIL HGSIL
EP 20 (56%) 16 (44%) 8 (22%) 8 (22%)
E-350G 11 (50%) 11 (50%) 7 (32%) 4 (18%)
E-6862C 2 (nc) 1 (nc) 1 (nc) —
Af1-a 3 (50%) 3 (50%) 3 (50%) —
Af2-a 1 (nc) 1 (nc) 1 (nc) —
AA-a — 1 (nc) — 1 (nc)
No statistically significant difference detected in the frequency
distribution of variants regarding histopathological sample sta-
tus. LGSIL: low-grade squamous intraepithelial lesion; HGSIL:
high-grade squamous intraepithelial lesion; nc: not compared
due to low data registry.pattern for the targeted HPV16 E6 and L1 regions in each
specimen examined. Combined hybridization patterns were
assigned on the basis of the predicted HPV16 class, subclass,
or minor class variants reported previously.11
Statistical analysis
Association analysis between histopathological status and
HPV16 variants was carried out by x2, calculated using the
Epi-Info 6.0 program (Epidemiology Program Office, Division
of Public Health Surveillance and Informatics, Centers for
Disease Control and Prevention, USA).
Results
Study population characteristics
Seventy samples from Guarani Indian women, catalogued as
mono-infected with HPV16 from a previous epidemiological
HPV screening analysis carried out during the years 2002—
2003 were selected for this study.22
There was no statistically significant association between
any of the population characteristics and HPV16 infection or
cervical disease as analyzed by means of x2. Furthermore,
the distribution of lesions over the population regarding
settlement area showed no statistically significant differ-
ences (Table 2).
HPV16 variants
The data allowed the identification and classification of the
major class and subclass variants of HPV16 infecting this
aboriginal population. The distribution of HPV16 variants
was 36 (51%) EP (European prototype), 22 (32%) E-350G,
six (9%) Af1-a (African 1), three (4%) E-6862C, two (3%)
Af2-a, and one (1%) AA-a (Asian-American).
The distribution of variants was not homogeneous in the
two geographical regions under analysis, the northern areaTable 3 Distribution of HPV16 E6 and L1 variants in the
regions under study
HPV16 variant Northern area Central area
EP 17 (50%) 19 (53%)
E-350G 5 (15%) 17 (47%)
E-6862C 3 (9%) —
Af1-a 6 (18%) —
Af2-a 2 (6%) —
AA-a 1 (2%) —
Table 2 Histopathological profile of the population of Guar-
ani women under study
Region n Normal LGSIL HGSIL
Northern area 34 17 (24%) 11 (16%) 6 (9%)
Central area 36 20 (28%) 7 (10%) 9 (13%)
Total 70 37 (53%) 18 (26%) 15 (21%)
LGSIL: low-grade squamous intraepithelial lesion; HGSIL: high-
grade squamous intraepithelial lesion.being more diverse, showing 74% of European variants and
26% of other classes, while the central area presented exclu-
sively European variants (Table 3). In both areas the most
frequent variant was EP, followed by the sub-class E-350G.
The distribution of variants among samples regarding their
histopathological status showed no statistically significant
association when analyzed by means of x2 (Table 4).
Discussion
In this study the distribution of HPV16 E6 and L1 variants in a
particular indigenous population — Guarani women inhabit-
ing the last remnant of rainforest in Argentina — has been
analyzed. This ethnic group presents particular character-
istics from the social, geographical, nutritional, and health
related standpoint. Their limited access to public health
programs and relatively scarce contact with the urban popu-
lation lasting for decades is changing rapidly, bringing impor-
tant modifications in their way of living and affecting their
health status. The northern area, at the borders with Brazil
and Paraguay, has been experiencing an explosive migratory
flux during the last decade. This situation has pushed male
Guarani Indians to leave their ancient settlements for
extended periods in order to work in rural duties or to sell
their products to tourists or white neighbors.
The recently reported epidemiological survey of HPV
carried out in this population22 detected a high prevalence
of generic HPV cervical infection (64%) and the presence of
oncogenic HPV types (26%). Also noteworthy was the impor-
tant viral diversity detected (24 different viral types), includ-
ing high- to intermediate-risk types not previously found in
the region. This situation contrasted sharply with the only six
HPV types found in the white urban population residing in
nearby areas.21
All Guarani women detected asmono-infected with HPV16
in the screening program were selected for variant analysis
and included in this work. This particular group showed a high
prevalence of cervical lesions, with 47% of them being
affected with some squamous intraepithelial lesion, 19% of
these high-grade.
It has already been well established that a persistent
cervical infection with HPV16 is associated with the devel-
opment of premalignant lesions and cervical cancer.15,25
Several findings suggest that different natural variants of
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behavior. Recent research has found that certain HPV16
variants tend to be more strongly associated to high-grade
intraepithelial lesions and cancer26,16 and that their distribu-
tion, defined on the basis of geographical relatedness, is
associated to ethnicity.18
The present study detected a high prevalence of European
class variants, representing 87% of the total over the entire
HPV16 infected Guarani Indian population, with the proto-
type being the most common strain found (51%), followed by
the variant E-350G (32%). These results are in agreement
with the only worldwide study of HPV16 variants in cervical
cancers done to date. In that work, Yamada et al.11 found 76%
of European class variants with 52% of subclass E-350G in 228
samples from Central and South America. Recently, del
Refugio Gonza´lez-Losa et al.27 reported 69% of European
class, with 27.5% being of the E-350G subclass in 40 samples
of LGSIL and cervical cancer from Mexican women.
Few non-European class variants were detected in the
Guarani population, accounting for 12% of the total. The
African class 1 was the most detected, representing 9%
among them. Surprisingly only one Asian-American variant
was detected. These results contrast with those reported by
Yamada et al.,11 where Asian-American variants accounted
for 20% of the total present in carcinomas from Central and
South America, and African variants only 3%.
Of particular interest is the distribution of these non-
European class variants, for all of them were found in one
geographical area, the northern region. The Indian settle-
ments of this region are situated over the borderlines with
Paraguay and Brazil, being separated only by rivers, and
exposed to strong migratory flux over the last two decades.
This situation contrasts sharply with those Indian settlements
situated in the central region, these being more isolated and
avoiding periodical contact with urban populations. Notice-
ably, only European class HPV16 variants were detected in
Guarani women inhabiting this area.
Taking into account that recombination events between
HPV16 variants are nonexistent or very rare,11 these findings
may represent different waves of HPV viral spread associated
to historical human migration patterns — E class variants
being introduced primarily by the Spanish conquerors that
colonized these areas, and Af variants from African slaves
introduced later in the South American continent.28
The only study of HPV16 variants performed on Indians
inhabiting Argentina reported to date is that of Picconi
et al.29 They analyzed 106 HPV16 positive cervical samples,
including 33 LGSIL, 28 HGSIL, nine invasive cervical cancer,
and 36 samples from women with normal colposcopy and
cytology from the Quechua Indian population inhabiting the
northwest part of Argentina, at the borders with Bolivia and
Chile in the Andean mountains. Their results showed that
only about 10% of the specimens had non-European variants,
but these included eight Asian-American, two Asian, one
North-American-1 and no African variants, and found a sta-
tistically significant association between the E-350G variant
presence and severity of lesion.
This report provides preliminary support to the hypothesis
that human migration at the western side of Argentina
brought in the original ancient variant from Asia, while that
at the eastern side has incorporated variants as a result of
more recent movements such as the introduction of Africanslaves in Brazil. However the influence of several other
factors like founder effects, co-evolution of HPVs with human
races, and viral transmissibility cannot be ruled out. In
particular, specific human leukocyte antigen (HLA) alleles
may influence the immune response to HPV infection, making
possible a preferential HPV type selection by hosts associated
to defined genetic backgrounds.26,30 The question of whether
particular ethnic groups are more susceptible to specific HPV
types/variants is still controversial and should be further
studied.31
Although several reports have suggested that the risk of
developing a cervical lesion is not the same with all variants
of HPV16, the non-prototype ones being more carcino-
genic,16,18,20,27,29 no statistically significant difference
among these variables was detected in the Guarani popula-
tion analyzed. Despite the fact that the number of samples
analyzed is small, they represent more than 90% of the local
sexually active Indian female population, establishing their
epidemiological profile. It will be of interest to compare the
dynamics of the particular HPV16 variants actually present in
these aboriginals with those circulating in the white urban
population of the region.
The World Health Organization has recommended extend-
ing HPV epidemiological studies particularly to those popula-
tions showing high prevalence of cervical cancer, in order to
contribute to vaccine formulations. This work provides pri-
mary data regarding HPV16 variants circulating in a semi-
closed aboriginal society, the Guarani Indians from north-
eastern Argentina. The identification of the variants present
in this particular community adds valuable information to
worldwide epidemiological surveys and will allow, in the near
future, the generation of amap of HPV circulation in northern
Argentina and nearby nations.
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